[Analysis of the Correlation between Immune Cell Subsets in Bronchoalveolar Lavage Fluid and the Efficacy of First-line Use of Immunotherapy in Advanced Non-small Cell Lung Cancer: A Case-control Study].
The proportions of total lymphocytes and T helper cells in BALF could be used as predictive biomarkers for first-line immunotherapy in late stage NSCLC. A multivariable model improves predictive accuracy.
Authors
- Wei Song (ORCID: https://orcid.org/0000-0003-0166-2308)
- Kai Zhang (ORCID: https://orcid.org/0000-0003-4237-3115)
- Tong Li (ORCID: https://orcid.org/0000-0002-4283-0091)
- Hongxia Li (ORCID: https://orcid.org/0000-0003-2831-0572)
- Tongmei Zhang (ORCID: https://orcid.org/0000-0003-4271-3773)
- Liang Shi (ORCID: https://orcid.org/0009-0009-6058-4785)
Institutions
- Capital Medical University (CN)
- Beijing Chest Hospital (CN)
Publication Details
- Journal
- PubMed
- Published
- 2024-12-20
- DOI
- https://doi.org/10.3779/j.issn.1009-3419.2024.101.32
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article